[1]
S. Navath and P. A. N. Navath, “Imatinib ‘Miracle Medicine’ for the Treatment of Ph+ Chronic Myeloid Leukemia (CML)”, International Journal of Cancer Therapeutics, vol. 1, no. 1, pp. 33-36, Jan. 2024.